Studying where medulloblastoma starts in the brain
Part of Cancer clinical trials.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be scheduled for surgery to remove a medulloblastoma brain tumor
- Patients of any age are welcome, including children under 18 and adults over 18
- You must be treated at a hospital that has a team of pediatric brain tumor experts
- You should not have severe bleeding from the tumor before surgery that would affect MRI scans
- During surgery, there must be no heavy bleeding that blocks the view of brain structures
- After surgery, lab tests must confirm the diagnosis of medulloblastoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This study looks at tumor tissue from children and young adults with a specific type of brain tumor called medulloblastoma. The goal is to understand the tumor better and find new ways to treat it.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
Hear when a new Medulloblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.